Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107466 · ClinicalTrials.gov registry record
Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss
A clinical trial of Hearing Loss and Sensorineural Hearing Loss, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05107466: Recruiting study of Hearing Loss and Sensorineural Hearing Loss, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05107466 is a study of Hearing Loss and Sensorineural Hearing Loss that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 100 participants, below the 6,119-participant average among 58 other Hearing Loss trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05107466, a study of Hearing Loss and Sensorineural Hearing Loss, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing loss. This test measures the participant's brain's response (so called "brain waves") to specific visual images. This study will help the investigators determine whether this test could be used to improve treatments for patients with hearing loss. The "Visual Evoked Potential" measurement test is already used in the investigator's Neurology clinic at Dartmouth Hitchcock Medical Center for various conditions to measure "early" brain responses that occur in the first 1-2 seconds after a new cue. Our research aims to explore your brain's response just after that early 1-2 second period by looking at a specific response called the "P300". The P300 wave is a brain response to new or different images or sounds. A visual evoked P300 has not been studied in individuals with hearing loss. The investigators will compare the results of this test to standard auditory tests, tests of cognitive function, and cochlear implant patient outcomes to explore how these factors can predict successful use of a hearing aid or cochlear implant.
Primary Outcome
Difference in P300 VEP latency to odd ball paradigm visual stimuli in individuals with hearing loss and normal hearing controls. Differences in VEP latency will be measured by recording onset time of the P300 signal from time of stimuli presentation.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST P300 Visually evoked potential
Study Locations (1)
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-07-28 |
| Est. Completion | 2026-10-01 |
What NCT05107466 shows while recruiting
NCT05107466 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 6,119-participant average among 58 other Hearing Loss trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which P300 Visually evoked potential is the first listed.
NCT05107466 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05107466 about?
NCT05107466 is a clinical study titled "Quantification of Visually Evoked Cortical Potentials in Individuals With Hearing Loss". This research is being done to determine whether a test that measures a "Visual Evoked Potential" can be used in a new way for individuals that have hearing loss. This test measures the participant's brain's response (so called "brain waves") to specific visual images. This study will help the inves...
What is the current status of trial NCT05107466?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-07-28. Estimated completion is 2026-10-01.
What conditions does trial NCT05107466 study?
This clinical trial studies the following conditions: Hearing Loss, Sensorineural Hearing Loss.
What interventions are being tested in trial NCT05107466?
The interventions under investigation include: P300 Visually evoked potential (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05107466?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05107466 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05107466's enrollment target sits among peer trials
100 30th of 58 higher than 28 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors
RECRUITING · Phase 1
-
NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI